Trial Condition(s):
EYLEA [AMD-QOL(Age-Related Macular Degeneration-Quality of Life)] post-marketing surveillance in Japan
The objective of this survey is to evaluate effectiveness of EYLEA on Quality of Life (QOL). The QOL is evaluated by using Japanese version (v.1.4 - interviewer administered format) of National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) and compared at baseline and at the 6 and 12 months after start of EYLEA treatment.
- Patients who have been determined to start EYLEA treatment - Patients who are registered to Special drug use investigation of EYLEA for AMD(Trial Number 15858) - Patients who have agreed with the patient informed consent
- Patients who have already received EYLEA
Locations | Status | ||
---|---|---|---|
Locations Investigative Site Many Locations, Japan | Status Completed | Contact Us: E-mail: [email protected] Phone: 49 30 300139003 |
Special Drug Use Investigation of EYLEA for Quality of Life
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1